NeutriSci International Inc.
NRXCF
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 44.20K | 46.10K | 222.60K | 357.20K | 340.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.20K | 46.10K | 222.60K | 357.20K | 340.00K |
| Cost of Revenue | 107.50K | 112.30K | 295.40K | 433.60K | 456.90K |
| Gross Profit | -63.20K | -66.10K | -72.70K | -76.30K | -116.70K |
| SG&A Expenses | 355.20K | 357.50K | 416.70K | 501.10K | 612.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 462.60K | 469.70K | 712.00K | 934.50K | 1.07M |
| Operating Income | -418.50K | -423.70K | -489.60K | -577.50K | -729.30K |
| Income Before Tax | -409.20K | -417.00K | -493.60K | -593.20K | -721.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.41 | -0.42 | -0.49 | -0.59 | -0.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -409.20K | -417.00K | -493.60K | -593.20K | -721.30K |
| EBIT | -418.50K | -423.70K | -489.60K | -577.50K | -729.30K |
| EBITDA | -394.50K | -398.20K | -462.50K | -548.70K | -698.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 701.20M | 688.90M | 676.60M | 664.61M | 664.58M |
| Average Diluted Shares Outstanding | 701.20M | 688.90M | 676.60M | 664.61M | 664.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |